KRH 2731
Alternative Names: KRH-2731-5HClLatest Information Update: 10 Dec 2007
Price :
$50 *
At a glance
- Originator Kureha Corporation
- Class Antiretrovirals
- Mechanism of Action CXCR4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections